文献速递冠心病

CABG术后晚期静脉桥血管病变:桥血管与自身血管介入策略比较

[Comparison of graft vessel versus native vessel strategies for late saphenous vein graft disease after coronary artery bypass grafting].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2020-01-01

该研究回顾性纳入165例CABG术后1年内因心绞痛复发且造影证实至少1支静脉桥血管狭窄≥50%的患者,比较桥血管介入(53例)与自身冠状动脉介入(112例)的疗效。两组手术成功率及严重并发症发生率无统计学差异,自身冠状动脉组住院病死率更低;出院12个月内MACE发生率及累积无事件生存率无统计学差异。急性冠状动脉综合征及合并外周血管疾病是介入治疗后MACE的独立危险因素。

要点

  • 桥血管与自身血管介入的手术成功率均较高且安全性良好。
  • 自身冠状动脉介入的住院病死率低于桥血管介入。
  • 急性冠脉综合征及外周血管疾病提示介入后预后较差。

核心结论

  • CABG术后晚期SVGD患者行静脉桥血管或自身冠状动脉介入治疗的手术成功率均较高、安全性均较好。
  • 自身冠状动脉介入治疗的住院期间病死率低于静脉桥血管介入治疗。
  • 合并急性冠状动脉综合征及外周血管疾病的患者介入治疗后预后较差。

研究设计与样本

  • 纳入术后1年因心绞痛复发住院且造影证实至少1支静脉桥血管狭窄≥50%的165例患者。
  • 按介入治疗部位分为静脉桥血管组53例与自身冠状动脉组112例。

主要发现

  • 静脉桥血管组手术成功率90.57%(48/53),严重并发症5.66%(3/53),死亡3.77%(2/53)。
  • 自身冠状动脉组手术成功率88.39%(99/112),严重并发症6.25%(7/112),无死亡。
  • 两组手术成功率及严重并发症发生率差异均无统计学意义(P均>0.05),自身冠状动脉组住院病死率低于桥血管组(P<0.05)。
  • 出院12个月内MACE发生率桥血管组11.32%(6/53)与自身冠状动脉组10.71%(12/112)差异无统计学意义(P>0.05)。
  • 累积无事件生存率桥血管组73.58%(39/53)与自身冠状动脉组66.13%(74/112)差异无统计学意义(P>0.05)。

关键数值与推荐

  • 多因素Cox回归显示急性冠状动脉综合征为MACE独立危险因素(HR=41.203,95%CI 4.859~349.361,P<0.01)。
  • 合并外周血管疾病为MACE独立危险因素(HR=2.808,95%CI 1.067~7.393,P<0.05)。

临床怎么用

  • 对于CABG术后晚期SVGD患者,桥血管与自身血管介入均可作为再血管化选择。
  • 自身冠状动脉介入可能降低住院期间死亡风险,决策时可结合造影结果及术者经验判断缺血相关血管。
  • 对合并急性冠状动脉综合征或外周血管疾病的患者应加强风险评估与随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare clinical efficacy of interventional treatment with graft vessel and native coronary artery for patients with late saphenous vein grafts disease(SVGD) after coronary artery bypass grafting (CABG). Methods: A total of 1 608 patients underwent CABG in Tianjin Chest from March 2014 to December 2017 were screened. During the follow-up period, 165 hospitalized patients with recurrence of angina pectoris within one year after CABG, who had at least one narrow vein graft(≥50%) confirmed by the coronary angiography were enrolled. According to the results of angiography and surgeon's clinical experiences, the patients received interventional treatment to vein grafts(grafts group, n=53) or native coronary vessels(native group, n=112). The operation success rate, mortality and incidence of serious complications after interventional treatment in two groups at the time of hospitalization were compared.And the incidence of major adverse cardiovascular events(MACE) in two groups at one year after discharge were also compared. Kaplan-Meier survival curve was used to compare the cumulative event-free survival rates. The risk factors for the MACE in the patients with late SVGD and treated by interventional therapy were analyzed by Cox regression analysis. Results: A total of 165 patients were included for analysis, including 98 males(59.4%). The age was (64.2±7.1) years old. The follow-up time was 12 (8, 12) months. In the grafts group, operation success rate was 90.57%(48/53), and 3 cases(5.66%) suffered from serious complications after interventional treatment, 2 cases(3.77%) died. For native group the operation success rate was 88.39%(99/112), and 7(6.25%) cases suffered from serious complications after interventional treatment, and no deaths. The operation success rate and the incidences of serious complications after interventional treatment in two groups had no statistically significant difference(both P>0.05). The mortality in hospital of native group was lower than that in grafts group(P<0.05). Within 12 months after discharge, there was no statistically significant difference in incidence of MACE of two groups (11.32%(6/53) vs. 10.71%(12/112), P>0.05). Survival analysis showed that the cumulative event-free survival rates in two groups were 73.58% (39/53) and 66.13%(74/112), and there was no statistically significant difference (P>0.05). Cox regression analysis showed acute coronary syndrome (HR=41.203, 95%CI 4.859-349.361, P<0.01), and peripheral vascular diseases (HR=2.808, 95%CI 1.067-7.393, P<0.05) were the risk factors of the MACE for the patients treated by interventional therapy with late SVGD. Conclusion: For the patients with late SVGD after CABG, the success rate of intervention with vein grafts and own coronary vessels are both high with satisfactory safety.The in-hospital mortality of interventional therapy in own coronary vessels is lower than in graft vessel. Patients with acute coronary syndrome and peripheral vascular disease have a poor prognosis. 目的: 对比分析冠状动脉旁路移植术(CABG)后晚期静脉移植血管疾病(SVGD)患者于静脉移植血管及自身冠状动脉进行介入治疗的临床效果。 方法: 2014年3月至2017年12月于天津市胸科医院登记的1 608例CABG术后患者中筛选术后1年因心绞痛症状复发住院且冠状动脉造影证实至少1支静脉移植血管狭窄≥50%患者165例。根据造影结果及术者临床经验判断缺血相关血管并对静脉移植血管或自身冠状动脉行介入治疗,依据介入治疗部位将纳入患者分为静脉移植血管组(53例)及自身冠状动脉组(112组)。对比两组的手术成功率、严重并发症及住院期间病死率,比较两组出院12个月内主要不良心血管事件(MACE)发生率。采用Kaplan-Meier生存曲线比较两组患者的累积无事件生存率,并采用Cox回归分析晚期SVGD患者介入治疗后发生MACE的危险因素。 结果: 最终纳入165例进行分析,其中男性98例(59.4%),年龄(64.2±7.1)岁。随访时间12(8,12)个月。静脉移植血管组的手术成功率为90.57%(48/53),住院期间3例(5.66%)发生严重并发症,2例(3.77%)死亡。自身冠状动脉组的手术成功率88.39%(99/112),住院期间7例(6.25%)发生严重并发症,无死亡病例。两组手术成功率及严重并发症发生率差异均无统计学意义(P均>0.05),自身冠状动脉组的住院期间病死率低于静脉移植血管组(P<0.05)。出院12个月内静脉移植血管组MACE发生率与自身冠状动脉组差异无统计学意义[11.32%(6/53)比10.71%(12/112),P>0.05]。Kaplan-Meier生存分析表明两组累积无事件生存率差异亦无统计学意义[73.58%(39/53)比66.13%(74/112),P>0.05]。多因素Cox回归分析显示,急性冠状动脉综合征(HR=41.203,95%CI 4.859~349.361,P<0.01)及合并外周血管疾病(HR=2.808,95%CI 1.067~7.393,P<0.05)为晚期SVGD患者介入治疗后发生MACE的独立危险因素。 结论: CABG术后晚期SVGD患者行静脉移植血管及自身冠状动脉介入治疗的手术成功率均较高,安全性均较好;自身冠状动脉介入治疗患者的住院期间病死率较静脉移植血管介入治疗患者低;伴有急性冠状动脉综合征及外周血管疾病的患者预后较差。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li XW, Liu Y, Gao J, et al. [Comparison of graft vessel versus native vessel strategies for late saphenous vein graft disease after coronary artery bypass grafting]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32450652. doi:10.3760/cma.j.cn112148-20190827-00523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。